Aspirin may cut down colon cancer risks too
New York: The humble aspirin that you pop to ameliorate headache or a precaution against heart attack can also take on the dangerous colorectal cancer in people with a specific gene, a significant study shows.
“Individuals whose colons have high levels of a specific gene product - 15-hydroxyprostaglandin dehydrogenase (15-PGDH) RNA - dramatically reduce their chances of developing colorectal cancer by taking aspirin,” said the researchers.
Aspirin, however, provides no benefit to individuals whose colons show low levels of 15-PGDH, the researchers added.
"If you looked at the folks from the study who had high 15-PGDH levels and took aspirin, they cut their risk of colon cancer by half," said Sanford Markowitz, a professor at Case Western Reserve School of Medicine in the US.
"If you looked at the folks from the study that were low for 15-PGDH, they did not benefit at all from taking aspirin,” Markowitz added.
The extraordinary finding comes from a multi-institutional team that analysed data and other material from two long-term studies involving nearly 128,000 participants.
The study appeared in the journal Science Translational Medicine.
More from India
More from World
More from Sports
More from Entertaiment
- Why do politicians show concern about Dalits during elections only?
- Why do politicians show concern about Dalits during elections only? Part II
- Why do politicians show concern about Dalits during elections only? Part III
- Why do politicians show concern about Dalits during elections only? Part IV
- Rajinikanth's 'Kabali' releases early morning at 6 am in Mumbai!
- All Party meet for inclusive engagement of all stakeholders in J&K
- Brazil arrests terror group over plot to launch large scale attack at 2016 Rio Olympics
- US acts to block two mega-mergers in health insurance worth $91 billion
- Hardik Patel's movement restricted; FIR lodged against him too
- Kotak Mahindra Bank posts 4-fold jump in net profit in Q1